Berlin, Germany

Tom N Grossmann

This inventor holds 2 USPTO granted patents and 5 published patent applications. Top assignee: Harvard College. Active years: 2015.

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 74(Granted Patents)


Location History:

  • Berlin, DE (2015)
  • Dortmund, DE (2015)

Company Filing History:


Years Active: 2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tom N Grossmann: Innovator in Bifunctional Peptides

Introduction

Tom N Grossmann is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of bifunctional peptides. With a total of 2 patents, his work focuses on innovative solutions for medical treatments.

Latest Patents

Grossmann's latest patents include "Bifunctional stapled polypeptides and uses thereof" and "Beta-catenin targeting peptides and uses thereof." The first patent relates to bifunctional stapled or stitched peptides that can tether or bring into close proximity at least two cellular entities, such as proteins. This invention has potential applications in treating diseases like cancer and inflammatory conditions. The second patent involves β-catenin targeting peptides that are designed to address diseases associated with aberrant Wnt signaling, including various forms of cancer.

Career Highlights

Tom N Grossmann is affiliated with Harvard College, where he continues to advance his research in peptide technology. His innovative work has garnered attention in the scientific community, contributing to the understanding of peptide interactions and their therapeutic potential.

Collaborations

Grossmann has collaborated with notable researchers, including Gregory Lawrence Verdine and Tsung-Han Johannes Yeh. These partnerships have further enriched his research endeavors and expanded the impact of his inventions.

Conclusion

Tom N Grossmann is a distinguished inventor whose work in bifunctional peptides holds promise for advancing medical treatments. His contributions to biotechnology are paving the way for innovative solutions in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…